Drugs being explicitly developed to treat rare diseases are getting more expensive. An analysis by Reuters found that prices ...

President Donald Trump's claim that prescription drug prices will be reduced “almost immediately" under a new executive order is misleading.

HHS is taking “immediate steps” to implement President Donald Trump’s executive order, Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients — a key initiative aimed at ...

Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

Remarkably many of the drugs, including pembrolizumab, were not available throughout much of that period – yet ... did not factor in the cost of research and development, but Global Justice ...

Further, switching costs could also emerge from longer ... Biopharma companies seek to shorten the drug development period while maintaining the precision and accuracy necessary for regulatory ...

The average cost for a Big Pharma to develop ... risk than incremental improvements on launched drugs and are more time consuming both in development and through regulatory approval, the rewards ...